Dr. Robert Afra, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1251 Via Mil Cumbres, Solana Beach, CA 92075 Phone: 619-243-4882 Fax: 858-794-7675 |
News Archive
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
"Senate Finance Committee Chairman Max Baucus said Monday he intends to ease what he called the financial burden his health bill would impose on middle-income families, making adjustments financed in part by paring back the amount of deficit reduction in the legislation," The Wall Street Journal reports. "In an interview, the Montana Democrat said some $28 billion of the funds now dedicated to deficit reduction could be diverted into proposals that would make the bill more affordable to working-class Americans."
IMRIS Inc. ("IMRIS" or the "Company") today announced a new organization structure designed to position the Company to continue to meet the growing global demand for IMRIS solutions.
The South African government's program to prevent mother-to-child transmission (PMTCT) of HIV has reduced the rate of virus transmission to about 3.5 percent, "potentially sparing some 67,000 babies from HIV infection," according to research presented on Wednesday by the Medical Research Council at the 5th South African AIDS Conference in Durban, Health-e/allAfrica.com reports.
› Verified 8 days ago